Skip to content

Progress Pediatric Study

The Thai Pediatric HIV Disease Progression: An Observational Database

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01328288
Enrollment
840
Registered
2011-04-04
Start date
2009-01-31
Completion date
2015-09-30
Last updated
2016-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, HIV

Keywords

HIV related adverse events, Immunological failure, virological failure, quality of life, depression, genotypic resistance

Brief summary

The purpose of this study is to study the HIV disease progression in HIV-infected Thai children.

Detailed description

This is a multicenter, observational cohort study. HIV-infected children from 5 institutions are followed to assess HIV disease progression: 1. Bamrasnaradura infectious disease institute,2. Faculty of Medicine Siriraj Hospital, Mahidol University, 3. Chiangrai Prachanukroh Hospital, 4. Sanpatong Hospital and 5. HIV-NAT, Thai Red Cross AIDS Research Center.

Interventions

DRUGstandard ART according to the Thai Ministry of Public Health national guidelines

Patients may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.

Sponsors

Bamrasnaradura Infectious Diseases Institute
CollaboratorOTHER_GOV
Mahidol University
CollaboratorOTHER
Chiangrai Prachanukroh Hospital
CollaboratorOTHER
Sanpatong Hospital
CollaboratorUNKNOWN
The HIV Netherlands Australia Thailand Research Collaboration
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

1. age \< 18 years old 2. Have confirmed HIV infection (ELISA,HIV-DNA PCR,HIV-RNA PCR) 3. Signed consent form

Exclusion criteria

1. Hospitalization 2. Emergency case 3. Incomplete Medical Record

Design outcomes

Primary

MeasureTime frameDescription
HIV related adverse events1 yeartime to HIV related adverse events

Secondary

MeasureTime frameDescription
Immunological failure1 yeartime to immunological failure
virological failure1 yeartime to virological failure
quality of life1 yeartime to change of quality of life
depression1 yearwhen patient develops depression
genotypic resistance1 yeartime to genotypic resistance

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026